ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $121,000 | -40.1% | 3,455 | -51.8% | 0.00% | -100.0% |
| Q3 2020 | $202,000 | -89.2% | 7,171 | -87.6% | 0.00% | -87.5% |
| Q2 2020 | $1,877,000 | +2.8% | 57,962 | +29.3% | 0.01% | -20.0% |
| Q1 2020 | $1,826,000 | +6.4% | 44,844 | +61.0% | 0.01% | +25.0% |
| Q4 2019 | $1,716,000 | +380.7% | 27,860 | +467.9% | 0.01% | +300.0% |
| Q3 2019 | $357,000 | +0.6% | 4,906 | +14.0% | 0.00% | 0.0% |
| Q2 2019 | $355,000 | -38.6% | 4,302 | -47.4% | 0.00% | 0.0% |
| Q1 2019 | $578,000 | +150.2% | 8,176 | +59.6% | 0.00% | +100.0% |
| Q4 2018 | $231,000 | -36.0% | 5,122 | -19.8% | 0.00% | 0.0% |
| Q3 2018 | $361,000 | -88.5% | 6,387 | -92.0% | 0.00% | -94.1% |
| Q3 2015 | $3,145,000 | +3318.5% | 79,611 | +5301.0% | 0.02% | – |
| Q1 2015 | $92,000 | +114.0% | 1,474 | +93.9% | 0.00% | – |
| Q4 2014 | $43,000 | – | 760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |